Document Detail


Vitamin K1 Antagonisation is not Safe in High Thromboembolic Risk Patients with Over-anticoagulation.
MedLine Citation:
PMID:  24901290     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
We report a case of a fatal massive anterior acute myocardial infarction (AMI) after administration of vitamin K1 for over-anticoagulation following cardioembolism from mechanical mitroaortic valve prostheses associated with atrial fibrillation.
Authors:
Sébastien Champion; Cédric Cleophax; Sebastian Voicu; Marc Sirol; Nicolas Deye; Frédéric J Baud
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-6-6
Journal Detail:
Title:  Therapie     Volume:  -     ISSN:  0040-5957     ISO Abbreviation:  Therapie     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-6-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0420544     Medline TA:  Therapie     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2014 Société Française de Pharmacologie et de Thérapeutique.
Vernacular Title:
L'antagonisation par vitamine K1 n'est pas sûre chez les patients à haut risque thromboembolique.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antipsychotic Use in the Cohort PACA-Alz in Patients with Alzheimer's Disease and Other Dementia in ...
Next Document:  Use of Oral Drugs and Short Bowel Syndrome: an Analysis of Practices.